TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 28 Jun 2024, 10:28 BST

Official UK procurement notice

Ustekinumab and Omalizumab · UK public procurement notice

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)·Consortium: 2 public authorities

Framework agreement2 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)
Framework ceiling (notional)£70,000,000total for 2 lots · framework ceiling, not attributable revenue
Submissions closed 29 Jul 2024awarded 21 Aug 2024
Lots 2see the lot list below

What is being bought2 lots · detail below

Published requirement description

Supply of Ustekinumab and Omalizumab to NHS Scotland

CPV: Pharmaceutical products

How this framework works

From the published notice
Places
up to 6 suppliers · 6 bids on the busiest of 2 lots (1.0 per place) · 7 appointed (full)

Lots and requirements (2)Procurement structure

2 lots · no lot values published · evaluation weights differ by lot
Lot #1UstekinumabAwardedRenewal

Supply of Ustekinumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to a six (6) Framework Participants.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #2OmalizumabAwardedRenewal

Supply of Omalizumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to two (2) Framework Participants.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expireVariant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored

Lots publish different evaluation splits; there is no single procedure weighting.

LotQualityPriceSplit
1 · Ustekinumab5%95%
2 · Omalizumab5%95%
Conditions of participation2
  • Suitability

    Economic operators may be excluded from this competition if they are in breach of any

    situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

  • Technical & professional ability

    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement.

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid

    certification of BS EN ISO 9001 or equivalent.

    (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.

    Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the…
What this means for your bid
  • Price carries 95 points on every lot: a 10% discount moves about 9.5 points.
  • “Ustekinumab and Omalizumab” is a framework: the contest is a place on its panel, up to 6 suppliers, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
28 Jun 2024, 10:28 BST
Last source update
11 Sept 2024, 16:09 BST
Award evaluation window
29 Jul 2024 – …
Authority reference
NP47924de
FTS notice number
2024/S 000-029144
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-047344 Find a Tender
Contract terms
Electronic trading
electronic ordering
Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: (SC Ref:777753)

How it was run

Official notice
Run through: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Appointment period ends
29 Jul 2024, 12:00 BST
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bids opened
29 Jul 2024, 13:30 BST
Detailed submission instructions & authority contactsFrom official release

www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗

Timeline

29 Jul 2024 → 30 Oct 2024 · 4 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    29 Jul 2024, 12:00 BST
  2. Bids opened
    29 Jul 2024, 13:30 BST
  3. Notice published
    11 Sept 2024, 16:09 BST
  4. Bids must remain valid until
    30 Oct 2024, 23:59 GMT

Notice history

2 events · 2 releases on Find a Tender · since 11 Sept 2024
  1. Status changed to complete
    11 Sept 2024, 16:09 BST
  2. Buyer details updated
    11 Sept 2024, 16:09 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 7admitted to the panel · see the list ↓
Bids received 64 from SMEs · busiest of 2 lots
Contracts signed 2latest 21 Aug 2024

2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Ustekinumab

    Signed
    21 Aug 2024
    Value
    £11,680,128
    Status
    active

  • Omalizumab

    Signed
    21 Aug 2024
    Value
    £2,136,450
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Ustekinumab6bids · 6 electronic · 6 from abroad4——
2 · Omalizumab2bids · 2 electronic · 2 from abroad2——

Contracting authority & participating public bodies

2 public bodies on the notice

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authorityNHS & healthcareBody governed by public lawHealth The Jack Copland Centre,, 52 Research Avenue North, Heriot-Watt Research Park, Edinburgh, Scotland, EH12 9EBContact name, email, phone Published organisation website ↗

Dispute resolution & review bodies

  • Sherriff Court HouseReview body EdinburghContact email, phone

Framework contractors & participating bidders

7 commercial parties on the notice
  • Accord Healthcare LtdFramework contractor Sage House, 319 Piner Road, North Harrow, UK, HA1 4HF
  • Amgen LtdFramework contractor 240 Cambridge Science Park, Milton Road, Cambridge, UK, CB4 0WDContact phone
  • Celltrion Healthcare United Kingdom LimitedFramework contractor 1-7 The Switch, Slough, UK, SL1 1QPContact phone
  • Janssen-Cilag LtdFramework contractor 50-100 Holmers Farm Way, High Wycombe, South East, HP12 4DPContact phone
  • Novartis Pharmaceuticals UK LtdFramework contractor 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, UK, W12 7FQContact phone
  • STADA UK - Thornton & RossFramework contractor Linthwaite, Huddersfield, UK, HD7 5JNContact phone
  • SandozFramework contractor Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, UK, GU15 3YLContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.